Navigation Links
Nano-tech makes medicine greener
Date:11/3/2011

Over the last 5 years the Bionano Group at the Nano-Science Center and the Department of Neuroscience and Pharmacology at the University of Copenhagen has been working hard to characterise and test how molecules react, combine together and form larger molecules, which can be used in the development of new medicine.

The researchers' breakthrough, as published in the prestigious journal Nature Nanotechnology, is that they are able to work with reactions that take place in very small volumes, namely 10-19 liters. This is a billion times smaller than anyone has managed to work with before. Even more intriguing is the ability to do so in parallel for millions of samples on a single chip.

"We are the first in the world to demonstrate that it is possible to mix and work with such small amounts of material. When we reach such unprecedented small volumes we can test many more reactions in parallel and that is the basis for the development of new drugs. In addition, we have reduced our use of materials considerably and that is beneficial to both the environment and the pocketbook," says professor Dimitrios Stamou, who predicts that the method will be of interest to industry because it makes it possible to investigate drugs faster, cheaper and greener.

The team of professor Stamou reached such small scales because they are working with self-assembling systems. Self-assembling systems, such as molecules, are biological systems that organise themselves without outside control.

This occurs because some molecules fit with certain other molecules so well that they assemble together into a common structure. Self-assembly is a fundamental principle in nature and occurs at all the different size scales, ranging from the formation of solar systems to the folding of DNA.

"By using nanotechnology we have been able to observe how specific self-assembling systems, such as biomolecules, react to different substances and have used this knowledge to develop the method. The self-assembling systems consist entirely of biological materials such as fat and as a result do not impact the environment, in contrast to the materials commonly used in industry today (e.g. plastics, silicon and metals). This and the dramatic reduction in the amount of used materials makes the technique more environment friendly, 'greener'," explains Dimitrios Stamou, who is part of the Synthetic Biology Center and director of the Lundbeck Center Biomembranes in Nanomedicine.


'/>"/>

Contact: Dimitrios Stamou
stamou@sund.ku.dk
01-145-249-81658
University of Copenhagen
Source:Eurekalert

Related biology news :

1. Trustee makes donation to start new solar energy research center at Rensselaer
2. What makes an axon an axon?
3. Feed a cold, feed a fever: Research shows calorie cut makes it harder to fight flu
4. Fly guy makes memory breakthrough
5. Our unconscious brain makes the best decisions possible
6. Biophysical Reviews makes debut in 2009
7. Tree lizard’s quick release escape system makes jumpers turn somersaults
8. Rett Syndrome Research Trust advisor makes significant discovery
9. Peptides-on-demand: McGill researchers radical new green chemistry makes the impossible possible
10. Mount Sinai Hospital researcher makes stem cell breakthrough
11. Red wine vs. white? It makes no difference when it comes to breast-cancer risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2016)...   IdentyTechSolutions America LLC , a leading ... and a cutting-edge manufacturer of software and hardware ... seamless, integrated solutions that comprise IDT biometric readers ... provide IdentyTech,s customers with combined physical identification and ... and theft. "We are proud to ...
(Date:12/16/2016)... 2016 The global wearable medical device market, in terms ... from USD 5.31 billion in 2016, at a CAGR of 18.0% ... ... advancements in medical devices, launch of a growing number of smartphone-based ... among healthcare providers, and increasing focus on physical fitness. ...
(Date:12/15/2016)... Calif. , Dec. 15, 2016   WaferGen ... publicly held genomics technology company, announced today that on ... Listing Qualifications Department of The Nasdaq Stock Market LLC ... closing bid price of WaferGen,s common stock had been ... Accordingly, WaferGen has regained compliance with Listing Rule 5550(a)(2) ...
Breaking Biology News(10 mins):
(Date:1/16/2017)... 2017   Valentin A. Pavlov, PhD , associate ... and CEO of The Feinstein Institute for Medical ... how the nervous system regulates the immune system, which ... medicine devices to treat disease and injury. The ... The paper examines various studies which further ...
(Date:1/16/2017)... Jan. 16, 2017  Eurofins Genomics today announced the ... more customers to receive their primers in a shorter ... in quality found with other providers. Express oligos are ... at no additional fee. Researchers ... studies, including DNA sequencing, genotyping, site-directed mutagenesis, and cloning. ...
(Date:1/14/2017)... -- The Alliance for Safe Biologic Medicines (ASBM) today issued ... guidance on biologic naming: We commend ... importance of distinct naming for all biologics, including biosimilars. ... will bring to patients, including new treatment options and ... the Guidance dealing with suffix design remains at odds ...
(Date:1/13/2017)... Research and Markets has announced the addition of ... ... grow at a CAGR of 16.83% during the period 2017-2021. ... the global biopolymers market for 2017-2021. To calculate the market size, the ... products. The report also includes a a discussion of the key vendors ...
Breaking Biology Technology: